Guerbet
19.77
11-April-25 10:29:25
15 minutes delayed
Stocks
-0.33
-1.64%
Today's range
19.60 - 20.15
ISIN
FR0000032526
Source
Cboe
-
29 Sep 2021 11:00:54 By Nasdaq GlobeNewswire
-
Guerbet: 2021 half-year results
22 Sep 2021 10:54:05 By Nasdaq GlobeNewswire
-
Guerbet: Revenue at June 30, 2021
22 Jul 2021 10:46:33 By Nasdaq GlobeNewswire
-
Marc Massiot appointed to Guerbet’s Board of Directors
31 May 2021 11:00:00 By Nasdaq GlobeNewswire
-
22 Apr 2021 10:45:00 By Nasdaq GlobeNewswire
-
Guerbet: Additional information related to 2021 financial outlook
29 Mar 2021 01:25:59 By Nasdaq GlobeNewswire
-
24 Mar 2021 11:45:00 By Nasdaq GlobeNewswire
-
Guerbet: Gadopiclenol - positive results for Phase III clinical trials
24 Mar 2021 02:00:00 By Nasdaq GlobeNewswire
-
11 Feb 2021 10:45:00 By Nasdaq GlobeNewswire